review glp-1 Frontiers GNC Publishes Peer-Reviewed Guide on

Second, a February 2026 perspective paper argued that fiber may help support appetite, glucose stability, and weight management during and after GLP-1 treatment, while being explicit that fiber cannot replicate what the medication does

By targeting both pathways, Mounjaro not only improves glucose control but also reduces appetite and slows digestion

doi: 10.1172/JCI116186 30 NauckMAKleineNOrskovCHolstJJWillmsBCreutzfeldtW

Originally approved for type 2 diabetes, with some brands later receiving approvals for obesity and obstructive sleep apnea, these drugs are also being prescribed off-label for a range of conditions

The first (experimental) problem that has been clearly identified recently is that most of the AD models used in experimental studies are not clinically valid and therefore cannot be adequately translated into the clinic